PS

Philipp Sander

Investor at IndieBio

San Francisco Bay Area

Overview 

Philipp Sander is an Investor at IndieBio/SOSV with a ChemBio PhD from Scripps Research. He has successfully invested in companies like Reactosome, Rybodyn, Stream Genomics, and VIAN Therapeutics, focusing on sectors such as Chemicals, Diagnostics, Therapeutics, Pharmaceuticals, and BioTech in the San Francisco Bay Area. His career highlights include conducting due diligence, making strategic investments, and providing advisory support to startups in the human and planetary health sectors. Philipp's background in biochemistry, molecular biology, and venture capital has enabled him to contribute significantly to the growth and success of innovative companies in the biotech and healthcare industries.

Work Experience 

S

SOSV

  • Investment Analyst

    2024 - Current

    Investor with SOSV's IndieBio San Francisco covering sourcing, diligence, deals, and portfolio support. Are you building a startup in human or planetary health? Let's talk!

  • Venture Fellow

    2022

    Venture Fellow with IndieBio San Francisco covering sourcing, diligence, deals, and portfolio support. Are you building a startup in human or planetary health? Let's talk!

SOSV is a deep tech venture firm that invests from a startup's inception and operates the HAX and IndieBio programs.

sosv.com
R

Reactosome

  • Investor & Advisor

    2023

Reactosome creates a synthetic nucleus for safer, longer-lasting gene expression in gene therapy, avoiding DNA-based risks.

reactosome.com
RI

RyboDyn Inc.

  • Investor & Advisor

    2023

Rybodyn is a biotechnology research company that develops therapeutics to train the immune system to detect and eradicate cancer internally.

rybodyn.com
SG

Stream Genomics

  • Investor & Advisor

    2023

VT

VIAN Therapeutics

  • Investor & Advisor

    2023

TB

TippingPoint Biosciences

  • Advisor

    2023

TippingPoint Biosciences is developing therapeutics that target genome packaging states in diseases like cancer.

tippingpointbiosciences.com
I

IndieBio

  • Venture Fellow and beyond

    2022

TS

The Scripps Research Institute

  • Graduate Student Researcher

    2017 - 2024

    Thesis title: "Building a Technology Platform for DNA-encoded Chemical Library Selection using Cellular Phenotypes" DNA-encoded Chemical Library Selection Methodologies and Biophysical Chemistry Projects in the Lairson Laboratory, Department of Chemistry

Uo

University of Freiburg

  • Master's Student

    2016 - 2017

    Masters Student working on the biochemical basis for the magnetic sense of orientation in the Schleicher/Weber Lab, Institute of Physical Chemistry

University of Freiburg, Department of Internal Medicine I

  • Scientific Editor and Grant Writer

    2015 - 2017

    - Wrote and Edited Review and Primary Research Articles in Epigenetics and Hematology field - Edited and Coordinated successful grant application for a German Research Foundation (DFG) Research Unit, comprising 11 separate grant applications funded with 4.2 Million Euros

Education 

Investments 

Reactosome

Pre Seed

Total funding amount not yet available

Rybodyn

Pre-Seed

Total funding amount not yet available

Stream Genomics

Pre-Seed

Total funding amount not yet available

VIAN Therapeutics

Pre-Seed

Total funding: $280K

Articles About Philipp

Relevant Websites